4th Pediatric Infectious Diseases Conference
 
 
Home  Back   ISSN 0973 - 0958
 
User name :
Password :
Follow Us : Follow On Facebook Follow On Twitter Follow On Youtube
FIND DIAGNOSIS
FIND DIAGNOSIS
Find Diagnosis
Pedi Poll
Today's Poll
Should teicoplannin, colistin be used in case of neonatal sepsis where culture does not reveal any organism_?
No, it should be used only after drug sensitivity report
Yes, under guidance of an infectious disease expert
ANTIRETROVIRAL THERAPY IN HIV POSITIVE CHILDREN
Antiretroviral Therapy in HIV Positive Children
Indications For Starting Antiretroviral Therapy
Indications For Starting Antiretroviral Therapy
Dr Ira Shah
MD, DNB, DCH, FCPS
Pediatrician & Pediatric HIV Specialist

Continued...

What are the Antiretroviral drug schedules?


The ideal combination of antiretroviral therapy consists of 3 drugs minimum of which 2 NRTIs form the backbone. The 3 rd drug may either be a protease inhibitor or an NNRTI. Prior to initiation of antiretroviral therapy and on ART, one may need to monitor the child for disease progression (clinically, immunologically and virologically), monitor for potential side effects of antiretroviral therapy and watch for drug resistance.

Table 3 - Recommended Antiretroviral Regimens for Initial Therapy

Strongly Recommended
  • One highly active protease inhibitors (Nelfinavir or ritonavir) plus two nucleoside analogue reverse transcriptase inhibitors.
  • For children who can swallow capsules: the non-nucleoside reverse transcriptase inhibitor (NNRTI) Efavirenz ** plus two NRTIs, or Efavirenz plus Nelfinavir and one NRTI.

Recommended as an Alternative
  • NVP and two NRTIs.
  • ABC in combination with ZDV and 3TC.
  • Lopinavir/ritonavir with two NRTIs or one NRTI and NNRTI.
  • IDV or SQVsoft gel capsule with two NRTIs for children who can swallow capsules.

Offered only in Special Circumstances
  • Two NRTIs.
  • APV in combination with two NRTIs or ABC.

Not Recommended
  • Any monotherapy.
  • d4T and ZDV
  • ddC and ddI
  • ddC and d4T
  • ddC and 3TC

** There are currently no data on appropriate dosage of EFV in children under age three years.

Except for ZDV chemoprophylaxis administered to HIV -exposed infants during the first 6 weeks of life to prevent perinatal HIV transmission; if an infant is confirmed as HIV-infected while receiving ZDV prophylaxis, therapy should be changed to a combination antiretroviral drug regimen.

Table 4 - Side Effects of Antiretroviral Therapy

NRTI

Hepatitis, fatty liver, Lactic acidosis, pancreatitis, myopathy, peripheral neuropathy, cardiomyopathy, bone marrow suppression.

NNRTI

Rash, Granulocytopenia, Hepatotoxicity

PI

Hyperglycemia, lipodystrophy, hyperlipidemia, osteoporosis, diabetes, increased bleeding tendencies.


Specific side effects

NRTI
  • Bone marrow suppressionZDVZDV
  • Pancreatitis, neurotoxicityddIddI
  • Lactic acidosis, lipoatrophy, peripheral neuropathy, hyperlipidemiad4Td4T
  • Single mutation confers resistance3TC3TC
  • Hypersensitivity reactionABCABC

NNRTI
  • Stevens Johnson syndrome, hepatic failureNVPNVP
  • Neuropsychiatric side effectsEFVEFV
  • Teratogenic in pregnancyEFVEFV

PI
  • Lopinavir/RitonavirBitter tasteBitter taste
  • DiarrheaNelfinavirNelfinavir
  • NephrotoxicityIndinavirIndinavir

Changing Antiretroviral Therapy

There are certain virologic, immunologic and clinical guidelines to determine whether a child requires a change in the antiretroviral therapy. However, one may consider changing the schedule if there is progression of the disease, failure to thrive (without any cause), progressive neurodevelopment deterioration, or fall in immunologic classification. At least 2 measurements should be performed before considering a change in therapy. Ideally a drug resistance testing should be done to determine what would be the best alternative therapy to be started.

Conclusion

Antiretroviral therapy in children requires special precautions, monitoring for drug interactions, adverse effects of ART and drug resistance. An ideal, individualized rational regime may go a long way in managing an HIV infected child and ensure a normal life style for such a patient.

Last updated on 01-06-2004

How to cite this url

Shah I .Antiretroviral Therapy In HIV Positive Children.Pediatric Oncall [serial online] 2004 [cited 2004 June 1];1. Available from:




 
 
Educational Section
 
Disclaimer:
The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
 
copyright ©2011 website design & development by Levioza
Follow Us
Follow us on :
Folllow Us